ADME-Space: a new tool for medicinal chemists to explore ADME properties

[1]  Zhigang Zhou,et al.  Use of probiotics in aquaculture of China-a review of the past decade. , 2019, Fish & shellfish immunology.

[2]  Franco Lombardo,et al.  In Silico Prediction of Volume of Distribution in Humans. Extensive Data Set and the Exploration of Linear and Nonlinear Methods Coupled with Molecular Interaction Fields Descriptors , 2016, J. Chem. Inf. Model..

[3]  Jürgen Bajorath,et al.  Lessons learned from the design of chemical space networks and opportunities for new applications , 2016, Journal of Computer-Aided Molecular Design.

[4]  L. Goracci,et al.  Indole Based Weapons to Fight Antibiotic Resistance: A Structure-Activity Relationship Study. , 2016, Journal of medicinal chemistry.

[5]  Isidro Cortes-Ciriano,et al.  Identification of binding sites and favorable ligand binding moieties by virtual screening and self-organizing map analysis , 2015, BMC Bioinformatics.

[6]  Li Di,et al.  Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition. , 2014, Molecular pharmaceutics.

[7]  Franco Lombardo,et al.  Clearance mechanism assignment and total clearance prediction in human based upon in silico models. , 2014, Journal of medicinal chemistry.

[8]  Jean-Louis Reymond,et al.  Discovery of potent positive allosteric modulators of the α3β2 nicotinic acetylcholine receptor by a chemical space walk in ChEMBL. , 2014, ACS chemical neuroscience.

[9]  S. Shakir,et al.  An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making , 2014, BMJ Open.

[10]  Alban Arrault,et al.  Generative Topographic Mapping-Based Classification Models and Their Applicability Domain: Application to the Biopharmaceutics Drug Disposition Classification System (BDDCS) , 2013, J. Chem. Inf. Model..

[11]  Tomislav Šmuc,et al.  Accurate models for P-gp drug recognition induced from a cancer cell line cytotoxicity screen. , 2013, Journal of medicinal chemistry.

[12]  P. Vayer,et al.  New QSAR Models for Human Cytochromes P450, 1A2, 2D6 and 3A4 Implicated in the Metabolism of Drugs. Relevance of Dataset on Model Development. , 2013, Molecular informatics.

[13]  G. V. van Westen,et al.  Structure-Based Identification of OATP1B1/3 Inhibitors , 2013, Molecular Pharmacology.

[14]  A. Tropsha,et al.  Human Intestinal Transporter Database: QSAR Modeling and Virtual Profiling of Drug Uptake, Efflux and Interactions , 2013, Pharmaceutical Research.

[15]  Ruili Huang,et al.  Prediction of Cytochrome P450 Profiles of Environmental Chemicals with QSAR Models Built from Drug‐Like Molecules , 2012, Molecular informatics.

[16]  Alban Arrault,et al.  QSAR Modelling of CYP3A4 Inhibition as a Screening Tool in the Context of DrugDrug Interaction Studies , 2012, Molecular informatics.

[17]  Jürgen Bajorath,et al.  Exploring activity cliffs in medicinal chemistry. , 2012, Journal of medicinal chemistry.

[18]  Pär Matsson,et al.  Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. , 2011, Journal of medicinal chemistry.

[19]  David M. Shackleford,et al.  Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. , 2011, Journal of medicinal chemistry.

[20]  Tudor I. Oprea,et al.  A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. , 2011, Journal of medicinal chemistry.

[21]  Igor V. Tetko,et al.  Applicability Domains for Classification Problems: Benchmarking of Distance to Models for Ames Mutagenicity Set , 2010, J. Chem. Inf. Model..

[22]  Sanjay Srivastava.  Computational Strategies to Predict Effect of P-Glycoprotein Transporter Efflux and Minimize its Impact on the Penetration of Drugs into the Central Nervous System (CNS) , 2008 .

[23]  Loriano Storchi,et al.  New and Original pKa Prediction Method Using Grid Molecular Interaction Fields. , 2008 .

[24]  Tudor I. Oprea,et al.  Ligand-Based Virtual Screening by Novelty Detection with Self-Organizing Maps , 2007, J. Chem. Inf. Model..

[25]  Gerald M. Maggiora,et al.  On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..

[26]  C. Laggner,et al.  Why drugs fail--a study on side effects in new chemical entities. , 2005, Current pharmaceutical design.

[27]  N. Kruhlak,et al.  Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose. , 2004, Regulatory toxicology and pharmacology : RTP.

[28]  Han van de Waterbeemd,et al.  Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability , 2003 .

[29]  Stephen A. Wring,et al.  Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs , 2002, Journal of Pharmacology and Experimental Therapeutics.

[30]  Tudor I. Oprea,et al.  Pharmacokinetically based mapping device for chemical space navigation. , 2002, Journal of combinatorial chemistry.

[31]  A. Beresford,et al.  The emerging importance of predictive ADME simulation in drug discovery. , 2002, Drug discovery today.

[32]  Tudor I. Oprea,et al.  Chemography: the Art of Navigating in Chemical Space , 2000 .

[33]  M Pastor,et al.  VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  B Testa,et al.  Predicting blood-brain barrier permeation from three-dimensional molecular structure. , 2000, Journal of medicinal chemistry.

[35]  P. Carrupt,et al.  Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .

[36]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[37]  Teuvo Kohonen,et al.  The self-organizing map , 1990, Neurocomputing.

[38]  S. Walker,et al.  Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). , 1988, British journal of clinical pharmacology.

[39]  Cheng Huang,et al.  Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. , 2016, Cancer letters.

[40]  Poulos,et al.  UC Office of the President Recent Work Title Current Approaches for Investigating and Predicting Cytochrome P 450 3 A 4-Ligand Interactions Permalink , 2015 .

[41]  P. Vayer,et al.  UPLC–MS retention time prediction: a machine learning approach to metabolite identification in untargeted profiling , 2015, Metabolomics.

[42]  Leslie Z. Benet,et al.  Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System , 2004, Pharmaceutical Research.

[43]  F. A. Macias,et al.  a Structure-Activity Relationship (SAR) Study , 2004 .